SCHEMBL454099

SCHEMBL454099

CCOC(=O)Cn1ccc(NC(=O)c2ccccc2)nc1=O

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.50
NPC1 O15118 4/20 0.46
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
ABL1 P00519 1/20 0.45
RIN1 Q13671 1/20 0.45
ALDH1A1 P00352 4/20 0.45
LMNA P02545 1/20 0.45
F2 P00734 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C19 P33261 1/20 0.45
TSHR P16473 2/20 0.45
SMN1; SMN2 Q16637 3/20 0.44
RAB9A P51151 3/20 0.44
GAA P10253 1/20 0.44
KDM4E B2RXH2 1/20 0.44
POLB P06746 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8645717 0.87 RAB9A (0.51) MAPTNPC1KMT2AMEN1ABL1
SCHEMBL8299962 0.85 MEN1 (0.45) MAPTNPC1KMT2AMEN1ABL1
SCHEMBL452423 0.84 KMT2A (0.54) MAPTNPC1KMT2AMEN1ABL1
SCHEMBL22672647 0.84 MEN1 (0.54) MAPTNPC1KMT2AMEN1ABL1
SCHEMBL13672916 0.81 MAPT (0.46) MAPTKMT2AMEN1ABL1RIN1
SCHEMBL14310475 0.79 MAPT (0.50) MAPTKMT2AMEN1ABL1RIN1
SCHEMBL10047088 0.79 HTT (0.45) MAPTNPC1KMT2AMEN1ALDH1A1
SCHEMBL27057456 0.78 KMT2A (0.50) MAPTNPC1KMT2AMEN1ABL1
SCHEMBL27056608 0.78 KMT2A (0.47) MAPTNPC1KMT2AMEN1ABL1
SCHEMBL27056601 0.78 KMT2A (0.47) MAPTNPC1KMT2AMEN1ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8859490-B2 Peptide nucleic acid monomers and oligomers NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2014-10-14 US disclosed
US-20120065364-A2 PEPTIDE NUCLEIC ACID MONOMERS AND OLIGOMERS NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2012-03-15 US disclosed
US-20110245458-A1 PEPTIDE NUCLEIC ACID MONOMERS AND OLIGOMERS NANYANG TECHONOLOGICAL UNIVERSITY (SG) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120065364-A2 PEPTIDE NUCLEIC ACID MONOMERS AND OLIGOMERS SIN3A, POLR2H, CYTH3 MAPT 4315/4885NPC1 2684/4885KMT2A 3492/4885
US-20110245458-A1 PEPTIDE NUCLEIC ACID MONOMERS AND OLIGOMERS SIN3A, POLR2H, CYTH3 MAPT 4315/4885NPC1 2684/4885KMT2A 3492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.